文献速递心外重症与机械循环支持先天性心脏病外科

儿童心室辅助装置支持的使用及移植后生存获益存在种族差异

Racial disparity exists in the utilization and post-transplant survival benefit of ventricular assist device support in children.
PubMed 文献 · J Heart Lung Transplant · 2022-12-28

基于UNOS数据库2006至2021年6121例列名心脏移植儿童,黑人患儿病情最重且VAD使用比例最高,但非白人患儿VAD桥接移植后长期移植后生存显著较差,黑人种族独立预测死亡(HR 1.67)。

要点

  • 黑人患儿列名时病情最重,VAD使用比例最高(列名时11% vs 西班牙裔8%和白人8%)。
  • VAD移植后住院结局和1年移植后生存相当,但非白人长期移植后生存显著较差。
  • 多变量分析中黑人种族独立预测死亡(HR 1.67),白人种族具保护作用(HR 0.54)。

核心结论

  • 儿童VAD使用看似公平,病情最重者接受最多VAD;尽管移植前和移植早期获益相似,非白人儿童VAD桥接移植后总体移植后生存较差。

研究设计与样本

  • 使用UNOS数据库识别2006至2021年间列名心脏移植的6121例儿童(<18岁):黑人占22%、西班牙裔占21%、白人占57%。
  • 比较种族/族裔组间VAD使用、结局和移植后生存,采用多变量Cox比例风险分析(后向选择协变量)研究种族/族裔与VAD桥接移植后生存的关联。

主要发现

  • 黑人儿童列名时病情最重:UNOS状态1A/1比例高于西班牙裔和白人(p<0.001),严重功能受限比例高于西班牙裔和白人(p<0.001),正性肌力药需求高于西班牙裔(p<0.05)。
  • 非白人儿童公共保险比例更高。
  • 列名时VAD使用:黑人11% vs 西班牙裔8%和白人8%(黑人 vs 西班牙裔和白人 p=0.001);移植时VAD使用:黑人24% vs 西班牙裔21% vs 白人19%(黑人 vs 西班牙裔 p=0.001)。
  • 移植时所有VAD患者临床状态相当(功能受限、肾/肝功能不全、正性肌力药、机械通气组间p>0.05)。
  • VAD后住院结局和1年移植后生存相当,但非白人长期移植后生存显著较差(白人 vs 黑人和西班牙裔 p<0.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Children of minority race and ethnicity experience inferior outcomes postheart transplantation (HTx). Studies have associated ventricular assist device (VAD) bridge-to-transplant (BTT) with similar-to-superior post-transplant-survival (PTS) compared to no mechanical circulatory support. It is unclear whether racial and ethnic discrepancies exist in VAD utilization and outcomes. METHODS: The United Network for Organ Sharing (UNOS) database was used to identify 6,121 children (<18 years) listed for HTx between 2006 and 2021: black (B-22% of cohort), Hispanic (H-21%), and white (W-57%). VAD utilization, outcomes, and PTS were compared between race/ethnicity groups. Multivariable Cox proportional analyses were used to study the association of race and ethnicity on PTS with VAD BTT, using backward selection for covariates. RESULTS: Black children were most ill at listing, with greater proportions of UNOS status 1A/1 (p < 0.001 vs H & W), severe functional limitation (p < 0.001 vs H & W), and greater inotrope requirements (p < 0.05 vs H). Non-white children had higher proportions of public insurance. VAD utilization at listing was: B-11%, H-8%, W-8% (p = 0.001 for B vs H & W). VAD at transplant was: B-24%, H-21%, W-19% (p = 0.001 for B vs H). At transplant, all VAD patients had comparable clinical status (functional limitation, renal/hepatic dysfunction, inotropes, mechanical ventilation; all p > 0.05 between groups). Following VAD, hospital outcomes and one-year PTS were equivalent but long-term PTS was significantly worse among non-whites-(p < 0.01 for W vs B & H). On multivariable analysis, black race independently predicted mortality (hazard ratio 1.67 [95% confidence interval 1.22-2.28]) while white race was protective (0.54 [0.40-0.74]). CONCLUSIONS: Pediatric VAD use is, seemingly, equitable; the most ill patients receive the most VADs. Despite similar pretransplant and early post-transplant benefits, non-white children experience inferior overall PTS after VAD BTT.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Greenberg JW, Bryant R, Villa C, et al. Racial disparity exists in the utilization and post-transplant survival benefit of ventricular assist device support in children. J Heart Lung Transplant. 2022. PMID: 36710094. doi:10.1016/j.healun.2022.12.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。